An Experimental Treatment for POMC and LEPR Deficiency Obesity Appears Effective

According to a story from sectorpublishingintelligence.co.uk, the biopharmaceutical company Rhythm Pharmaceuticals, Inc., has recently announced the results from two phase 3 clinical trials. These trials were testing the company's experimental…

Continue Reading An Experimental Treatment for POMC and LEPR Deficiency Obesity Appears Effective

A Potential Treatment for Familial Chylomicronemia Syndrome Performs Well in Trials

According to a story from EurekAlert!, the results of a recent clinical trial should get the attention of patients in the US with the rare disorder familial chylomicronemia syndrome. The…

Continue Reading A Potential Treatment for Familial Chylomicronemia Syndrome Performs Well in Trials
Large Scale Trial Aims to Test Precision Medicines Based on Genomic Profiling in a Variety of Cancers
source: pixabay.com

Large Scale Trial Aims to Test Precision Medicines Based on Genomic Profiling in a Variety of Cancers

According to a story from Newswise, Quest Diagnostics, a laboratory that specializes in diagnostic information, has announced plans to participate in a unique, large scale trial called NCI-MATCH, which stands…

Continue Reading Large Scale Trial Aims to Test Precision Medicines Based on Genomic Profiling in a Variety of Cancers

Collaboration Between C-Path and NORD will Help Standardize Data and Accelerate Research for Rare Diseases

Critical Path Institute The Critical Path Institute, or C-Path is a nonprofit organization which was established in 2005. It has a US branch, headquartered in Tucson, Arizona as well as…

Continue Reading Collaboration Between C-Path and NORD will Help Standardize Data and Accelerate Research for Rare Diseases

Company Cleared to Begin Trials for Experimental Retinitis Pigmentosa Drug

According to a story from globenewswire.com, the drug developer ProQR Therapeutics N.V. has recently announced that the US Food and Drug Administration (FDA) has officially cleared the company's Investigational New…

Continue Reading Company Cleared to Begin Trials for Experimental Retinitis Pigmentosa Drug
If You Have IBD, You Have Access to Employee Bathrooms. If You’re an Employee, You Should Know That.
Source: www.pixabay.com

If You Have IBD, You Have Access to Employee Bathrooms. If You’re an Employee, You Should Know That.

In a story reported in the Boston Globe, Stephen Marcus, as a person with Crohn’s disease, knows the laws surrounding bathroom policies from public franchises. He worked as a lawyer…

Continue Reading If You Have IBD, You Have Access to Employee Bathrooms. If You’re an Employee, You Should Know That.

Electroencephalography Study Reveals The Impact of Amyotrophic Lateral Sclerosis on Neural Networks

According to a story from Trinity News, a team of researchers with the Academic Unit of Neurology at Trinity College Dublin have recently conducted a study that maps the ways…

Continue Reading Electroencephalography Study Reveals The Impact of Amyotrophic Lateral Sclerosis on Neural Networks
New Study Suggests Activity of Propranolol in Hypotrichosis-Lymphedema-Telangiectasia Patients
https://pixabay.com/en/tablets-pharmacy-medications-cure-2248375/

New Study Suggests Activity of Propranolol in Hypotrichosis-Lymphedema-Telangiectasia Patients

According to a publication from ScienceDaily, a new study of propranolol suggests explanations for its ability to shrink certain benign tumors in infants and relieve symptoms of hypotrichosis-lymphedema-telangiectasia syndrome. About…

Continue Reading New Study Suggests Activity of Propranolol in Hypotrichosis-Lymphedema-Telangiectasia Patients

Researchers Find Success in Precision Cutting as a Exciting New Treatment for Inflammatory Bowel Disease

As reported in EurekAlert, an exciting new treatment method has entered the conversation to treat inflammatory bowel disease (IBD). Researchers have successfuly used mice population to show that precision cutting…

Continue Reading Researchers Find Success in Precision Cutting as a Exciting New Treatment for Inflammatory Bowel Disease